Turkey Company Roundup: Biosimilar Pact, Keytruda Supply, Takeda Deal
This article was originally published in PharmAsia News
Executive Summary
TUBITAK (The Scientific and Technological Research Council of Turkey) will produce biosimilars with Nobel Ilac, MSD provides pembrolizumab free to 25 patients in Turkey, Abdi Ibrahim intensifies its R&D efforts, and Takeda purchases a portfolio of new products.